Project Number 3R01AI161374-02S1 Agency/Funding Organization NIAID Funding Year 2022 View Full Project Details for Development and characterization of engineered therapeutic antibodies against SARS-CoV-2 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator AMARASINGHE, GAYA K. Principal Investigator First Name GAYA K. Principal Investigator Last Name AMARASINGHE Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $393,750 Funding Organization Agency/Funding Organization NIAID Funding Organization Country United States Program Official BASU, DIPANWITA
